View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
May 7, 1997updated 05 Sep 2016 12:46pm


By CBR Staff Writer

An Oxford University professor is challenging Affymetrix Corp’s claim to be the inventor of the deoxyribonucleic acid chip (CI No 3,154). Professor Ed Southern has said the US company, which is part owned by Glaxo Wellcome Plc, is not the inventor, and that he invented the DNA chips and has a European patent, which is currently assigned to the university. The Financial Times says Affymetrix has begun discussions with Professor Southern to agree a licensing deal. Oxford University’s Gene Technology department is said to be near to launching its own product, but the Professor has said he will be granting licenses to other companies in a bid to encourage competition. The chips have been designed for rapidly analyzing human make-up and contain silicon and pieces of DNA.

Content from our partners
Green for go: Transforming trade in the UK
Manufacturers are switching to personalised customer experience amid fierce competition
How many ends in end-to-end service orchestration?

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.